Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

A woman had an unusual allergic reaction to a hair loss treatment, which cleared up after stopping the treatment and using a different medication.

A man developed an allergic skin reaction after using brimonidine for rosacea.

Low-level light therapy may reduce hair loss and improve hair quality but it's unclear who benefits most.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Valproic acid can cause a rare allergic reaction leading to fluid around the lungs and heart, which is treatable by changing medication.

Low vitamin D levels are linked to higher rates of hair loss in women.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Actual harvested hair follicles were fewer and differed in type from estimated, with older patients and those with multiple transplants needing more careful planning.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Using a carbon dioxide laser and platelet-rich plasma together can effectively restore hair and patients are generally satisfied with the results.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.